On 06 de nov. de 2025, NVAX reported earnings of -1.25 USD per share (EPS) for Q3 25, missing the estimate of -1.21 USD, resulting in a -3.31% surprise. Revenue reached 70.44 milhão, compared to an expected 42.98 milhão, with a 63.92% difference. The market reacted with a -1.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.49 USD, with revenue projected to reach 80.88 milhão USD, implying an diminuir of -60.80% EPS, and aumentar of 14.81% in Revenue from the last quarter.
FAQ
What were Novavax Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Novavax Inc reported EPS of -$1.25, missing estimates by -3.31%, and revenue of $70.44M, 63.92% above expectations.
How did the market react to Novavax Inc's Q3 2025 earnings?
The stock price moved down -1.3%, changed from $7.69 before the earnings release to $7.59 the day after.
When is Novavax Inc expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Novavax Inc's next earnings report?
Based on 10
analistas, Novavax Inc is expected to report EPS of -$0.49 and revenue of $80.88M for Q4 2025.